A 54-year-old woman from Wuhan, China, the epicenter of the COVID-19 (formerly known as 2019 novel coronavirus \[2019-nCoV\]) outbreak ([@r1],[@r2]), presented with a 2-day history of fever. The physical examination revealed a temperature of 39.0°C, and laboratory studies showed normal leukocyte with a differential of 82.8% neutrophils, 9.5% lymphocytes, and 0.1% eosinophils. Screening for multiple respiratory pathogens, including influenza A, influenza B, respiratory syncytial virus, adenovirus, human parainfluenza virus, *Mycoplasma pneumoniae*, and *Chlamydia pneumoniae* was negative. At presentation, nonenhanced chest CT showed multifocal nodular opacities in multiple lobes ([Fig 1a](#fig1a){ref-type="fig"}). After 6 days of supportive treatment, follow-up CT showed decreased density of the opacities and development of ground glass and reversed halo sign ([Fig 1b](#fig1b){ref-type="fig"}). The initial nasopharyngeal swab test for the COVID-19 nucleic acids had been negative, but a second test confirmed infection. After 3 days of treatment with oseltamivir, follow-up CT showed significant improvement in the extent and density of the ground-glass opacities ([Fig 1c](#fig1c){ref-type="fig"}).
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